MULTISPEZIFISCHE ANTIGEN BINDENDE PROTEINE

European patent · EP3313876 · In force

Register entry

Publication number
EP3313876
Application number
EP16733394
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 23, 2016
Published
May 2, 2018
Granted
Jan 22, 2025
Protection ends at the latest
Jun 22, 2036
Next annual fee due
Jun 30, 2027
IPC classes
C07K 16/00 (2006.01)
C07K 16/28 (2006.01)
C07K 16/46 (2006.01)
Priority
WO PCT/EP2015/064070 23.06.2015
US 201562271491 P 28.12.2015
PCT application
PCT/EP2016/064528 23.06.2016
PCT publication
WO2016/207273 29.12.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. Dec 3, 2025

    Change

    Published in Swissreg on 03.12.2025

  3. Jul 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  4. Jan 22, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 22.01.2025

Parties

Holder

Innate Pharma

117, Avenue de Luminy, 13009 Marseille, FR

Inventor

GAUTHIER, Laurent

13008 Marseille, FR

ROSSI, Benjamin

13008 Marseille, FR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.